## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no access to full manuscript, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The study uses molecular dynamics and quantum mechanics, including density functional theory, to analyze six snapshots of the EWS-FLI1 oncoprotein, concluding that the protein is compact, electrophilic, and has localized reactive sites, with implications for targeted therapy development in Ewing sarcoma
- **Visible evidence base** Abstract text only; no methodological details, numerical results, or structural data provided
- **Missing materials affecting confidence** Full manuscript, all figures and tables, computational methods section, force field parameters, simulation protocols, convergence criteria, and any statistical analyses

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting computational study of a clinically relevant oncoprotein, but the information provided is insufficient to evaluate the technical soundness or validity of the claims. The conclusions regarding compactness, electrophilicity, and localized reactive sites are stated without supporting quantitative data or methodological context. The link to drug development is speculative and not substantiated by the abstract alone.
- **Who would be interested in the results, and why** Computational biophysicists and chemists studying protein reactivity and drug target characterization would be interested. Researchers in sarcoma biology and targeted therapy development may also find relevance, though the translational claims require stronger evidence.
- **Major strengths** The study addresses a clinically important target with limited structural and functional characterization. The combination of molecular dynamics and quantum mechanics is appropriate for probing reactivity properties. The focus on localized reactive sites is a sensible approach for identifying potential drug binding regions.
- **Major Concerns**  
  - R1-M1  
  - R1-M2  
  - R1-M3
- **Minor Comments**  
  - R1-m1  
  - R1-m2  
  - R1-m3
- **Technical failings that need to be addressed before the case is established** R1-M1, R1-M2, R1-M3
- **Assessment against Nature-style criteria**  
  Originality: The abstract does not clearly establish novelty beyond applying known computational methods to a specific protein. Scientific importance: The target is clinically relevant, but the abstract does not demonstrate that the findings advance understanding beyond existing knowledge. Interdisciplinary readership: The work may appeal to computational chemists and cancer biologists, but the abstract lacks sufficient context for broad appeal. Technical soundness: Cannot be assessed from the abstract alone; no methodological validation or error analysis is presented. Readability for nonspecialists: The abstract is generally clear but uses terms such as electrophilic and reactive sites without sufficient explanation for a general audience.
- **Recommendation posture** Currently not established from the provided evidence. The abstract does not provide enough detail to support the core claims, and the technical basis for the conclusions is not verifiable.

### Major Concerns

- **Concern ID** R1-M1  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Technical soundness  
- **Claim pointer** The study concludes that EWS-FLI1 is a compact, electrophilic protein with localized reactive sites  
- **Evidence pointer** Abstract; location not provided  
- **Concern** The abstract provides no quantitative metrics to support the claims of compactness, electrophilicity, or localization of reactive sites. No descriptors, energy values, or comparison to reference systems are given.  
- **Why it matters** Without numerical evidence or defined criteria, these claims are not falsifiable and cannot be evaluated by readers. The conclusions may be based on arbitrary thresholds or unvalidated computational measures.  
- **Resolution test** Provide specific computed values such as solvent accessible surface area, electrophilicity indices, Fukui functions, or electrostatic potential maps, with clear definitions and statistical uncertainty estimates.

- **Concern ID** R1-M2  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Reproducibility  
- **Claim pointer** The study uses molecular dynamics and quantum mechanics analyses on six snapshots of the EWS-FLI1 oncoprotein  
- **Evidence pointer** Abstract; location not provided  
- **Concern** The abstract does not describe the simulation protocol, force field, system setup, equilibration time, sampling length, or the criteria for selecting the six snapshots. The quantum mechanics method is only named as density functional theory without specifying functional, basis set, or level of theory.  
- **Why it matters** Reproducibility is a core requirement for computational studies. Without these details, the work cannot be repeated or independently verified, and the choice of six snapshots may introduce sampling bias.  
- **Resolution test** Include a full methods section with simulation parameters, snapshot selection criteria, convergence checks, and software versions. Specify the DFT functional and basis set used.

- **Concern ID** R1-M3  
- **Severity** Major  
- **Blocking** Yes  
- **Axis** Claim support  
- **Claim pointer** The findings provide valuable insights for potential drug development and enhance knowledge of Ewing sarcoma for targeted treatments  
- **Evidence pointer** Abstract; location not provided  
- **Concern** The abstract does not demonstrate a link between the computed reactivity properties and any drug binding or inhibition mechanism. No docking, ligand interaction, or experimental validation is mentioned.  
- **Why it matters** The translational claim is central to the stated motivation but is unsupported. Without evidence that the identified reactive sites are druggable or functionally relevant, the conclusion is speculative.  
- **Resolution test** Provide additional data such as druggability predictions, comparison with known binding pockets, or experimental validation of reactive site relevance.

### Minor Comments

- **Concern ID** R1-m1  
- **Severity** Minor  
- **Axis** Clarity  
- **Affected element** Definition of reactive sites  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The term reactive sites is used without defining what constitutes reactivity in this context, such as nucleophilic or electrophilic character, or specific residue involvement.  
- **Required correction** Define reactive sites operationally, for example by specifying the computational descriptor used to identify them and the residues involved.

- **Concern ID** R1-m2  
- **Severity** Minor  
- **Axis** Context  
- **Affected element** Comparison to prior work  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The abstract does not situate the findings within existing structural or computational studies of EWS-FLI1, so the incremental contribution is unclear.  
- **Required correction** Add a brief statement in the abstract or introduction comparing the current findings to prior computational or experimental characterizations of EWS-FLI1.

- **Concern ID** R1-m3  
- **Severity** Minor  
- **Axis** Generalizability  
- **Affected element** Snapshot sampling  
- **Evidence pointer** Abstract; location not provided  
- **Issue** The use of six snapshots is mentioned but the rationale for this number and the representativeness of the selected conformations is not explained.  
- **Required correction** Justify the snapshot selection, for example by clustering analysis or by showing that additional snapshots do not change the conclusions.

## Risk / unsupported claims
- The claim that EWS-FLI1 is compact is unsupported without quantitative structural measures.
- The claim that EWS-FLI1 is electrophilic is unsupported without defined reactivity descriptors or comparison values.
- The claim that reactive sites are localized is unsupported without spatial mapping or residue-level identification.
- The claim that the findings contribute to drug development is unsupported and speculative based on the abstract alone.
- The overall relevance to targeted treatments for Ewing sarcoma is not established from the provided evidence.